Figure 3 | Scientific Reports

Figure 3

From: Isoliquiritigenin, a potent human monoamine oxidase inhibitor, modulates dopamine D1, D3, and vasopressin V1A receptors

Figure 3

The docking pose of isoliquiritigenin (ILG) (green) at the catalytic binding site of hMAO-A (a). The docking poses of ILG at the catalytic (b) and allosteric (c) binding sites of hMAO-B. Key interaction molecules involved in catalytic site binding of hMAO-A (d) and hMAO-B (e) and at the allosteric site of hMAO-B (f) are represented by a two-dimensional binding diagram of ILG. H-bond, pi-pi-stack, pi-pi T-shaped, pi-sigma, and pi-alkyl interactions are shown with green, dark pink, violet, and light pink dashed lines, respectively.

Back to article page